Full name
CENTRUM KARDIOLOGICZNE AMICOR SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
CENTRUM KARDIOLOGICZNE AMICOR SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
UL. KRAKUSÓW 4, 30-092 KRAKÓW
TAX ID6770052042
Rate company:
CENTRUM KARDIOLOGICZNE AMICOR SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
TAX ID6770052042
KRS0000171612
Share capital387,500.00 zł
address
UL. KRAKUSÓW 4, 30-092 KRAKÓW
Categories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
6770052042
REGON
350005058
KRS
0000171612
Legal form
limited liability company
Register Address
UL. KRAKUSÓW 4, 30-092 KRAKÓW
Date of registration in KRS
2003-09-24
Date of commencement of economic activity
2003-09-24
Act signature
KR.XI NS-REJ.KRS/25504/22/486/ADE
Pkd codes
86.22.Z - Specialist medical practice
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
58.19.Z - Other publishing activities, excluding software publishing
62.02.Z - Activities related to programming, IT consulting, and related activities
72.19.Z - Scientific research and development activities
84.12.Z - Management of public services in health, education, culture, and other social services
85.59.B - Courses and training for acquiring knowledge, skills, and professional qualifications in non-school forms
86.21.Z - General medical practice
86.90.D - Healthcare
86.90.E - Healthcare
Payer VAT status
exempted
Vat list bank account(s)
PL41 1600 1039 0002 0035 0699 9001 
Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2021 | 2022 | 2023 | ||
|---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale  | 0,2 | 0,7 | 0,5 | -29,5 |
Gross profit (loss) | 0,4 | 0,7 | 0,5 | -28,7 |
EBITDA | 0,5 | 0,8 | 0,7 | -17,3 |
Short time liabilities | 0,3 | 0,2 | 0,3 | 35,6 |
Other operating costs | 0 | 0 | 0 | -88 |
Equity capital | 1,1 | 1,7 | 2,1 | 21,4 |
Operating profit (EBIT) | 0,4 | 0,7 | 0,5 | -28,7 |
Assets | 1,4 | 2 | 2,4 | 22,2 |
Net profit (loss) | 0,4 | 0,7 | 0,5 | -31,1 |
Cash | 0,4 | 0,8 | 1,2 | 51,7 |
Liabilities and provisions for liabilities | 0,3 | 0,3 | 0,3 | 27,3 |
Net income from sale | 4 | 4,7 | 5 | 6,1 |
Working assets | 1 | 1,4 | 1,8 | 27,6 |
Other income costs | 0,2 | 0 | 0 | -∞ |
Depreciation | 0,1 | 0,1 | 0,1 | 93,6 |
% | % | % | p.p. | |
Profitability of capital | 37,3 | 39,7 | 22,5 | -17,2 |
Equity capital to total assets | 77,8 | 86,7 | 86,2 | -0,5 |
Gross profit margin | 10,1 | 15,4 | 10,3 | -5,1 |
EBITDA Margin | 12,3 | 17 | 13,2 | -3,8 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 25 | 19 | 24 | 5 |
Current financial liquidity indicator | 3.579819679260254 | 5.656651020050049 | 5.324074745178223 | -0,4 |
Net dept to EBITDA | -0.7705132961273193 | -0.9553305506706238 | -1.7824769020080566 | -0,8 |
Financial statements
01-01-2023 - 31-12-2023
Annual financial report
Download xml01-01-2023 - 31-12-2023
Annual financial report
Download pdf01-01-2023 - 31-12-2023
Activity report
Download pdf01-01-2023 - 31-12-2023
Resolution on profit distribution or loss coverage
Download pdf01-01-2023 - 31-12-2023
Resolution or decision approving the annual financial statements
Download pdfShow more (2)
uses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.
Companies registered in the same sector
Med+reh Filip Pałczyński
Września